MST estimates assume that positive results in trofinetide’s Phase 3 trials and NNZ-2591’s Phase 2 trial will trigger milestone payments over CY21-CY23 of ~A$146m, almost equal to its current market cap.
Honestly, I can’t follow this analyst.
Firstly, my understanding was that there will be 3 Phase 2 trials of NNZ-2591 run simultaneously, so why use of the singular “trial”?
Secondly, why would the analyst consider that success in Phase 2 with NNZ-2591 will trigger milestone payments when Neuren hasn’t signed any deal for NNZ-2591?
- Forums
- ASX - By Stock
- NEU
- Updated MST report - target of $3.68 a share
Updated MST report - target of $3.68 a share, page-3
-
- There are more pages in this discussion • 217 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$15.59 |
Change
0.380(2.50%) |
Mkt cap ! $1.992B |
Open | High | Low | Value | Volume |
$15.51 | $15.82 | $15.46 | $11.26M | 722.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 696 | $15.59 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$15.67 | 6942 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 64 | 15.570 |
1 | 320 | 15.510 |
1 | 181 | 15.450 |
1 | 530 | 15.300 |
1 | 2500 | 15.250 |
Price($) | Vol. | No. |
---|---|---|
15.670 | 2340 | 1 |
15.800 | 20 | 1 |
15.810 | 316 | 1 |
15.850 | 800 | 1 |
15.900 | 500 | 1 |
Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
1CG
ONE CLICK GROUP LIMITED
Mark Waller, MD
Mark Waller
MD
Previous Video
Next Video
SPONSORED BY The Market Online